Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Article
  • Published:

Session II – Ethical Implications Of Genome Medicine

Gene therapy and the public: a matter of trust

Abstract

The relationship between genetic engineering and the public has never been a very harmonious one. Many scientists believe that public concerns about gene therapy are simply based on misunderstandings and lack of scientific information. In this ‘deficit theory’ of the public, most difficulties in the interaction between science and the public are derived from the assumption that there is a communication gap between scientists and the public. However, public opinion research shows clearly that the various ‘publics’ have a differentiated, and generally positive perception of medical biotechnology. It is not so much lack of information, as lack of trust which explains the difficult relationship between gene therapy and society. For the future, it will be crucial not only to focus on the idea of ‘educating the public’, but to find new communicative and institutional formats to generate trust.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Abbot A . Genetic Medicine gets real Nature 2001 411: 410–412

    Article  Google Scholar 

  2. Abbot A . Genetic Medicine gets real National Reference Center for Bioethics Literature. Hum Gene Ther. Scope Note 24, February 2000

  3. Flanagan N . Gene therapy for cancer Gene Eng News 2001 21: 71

    Google Scholar 

  4. Bensaude-Vincent B . A genealogy of the increasing gap between science and the public Pub Understand Sci 2001 10: 99–113

    Article  Google Scholar 

  5. Gaskell G et al. Biotechnology and the European public Nature Biotechnol 2000 18: 935–938

    Article  CAS  Google Scholar 

  6. Priest SH . Us public opinion divided over biotechnology? Nature Biotechnol 2000 18: 939–942

    Article  CAS  Google Scholar 

  7. Putnam R . Princeton University Press 1993

  8. Office of Science and Technology and the Welcome Trust.. Science and the public: a review of science communication and public attitudes toward science in Britain Pub Understand Sci 2001 10: 315–330

  9. Millstone E, Van Zwanenberg P . A crisis of trust: for science, scientists or for institutions? Nat Med 2000 6: 1307–1308

    Article  CAS  Google Scholar 

  10. Millstone E, Van Zwanenberg P . A crisis of trust: for science, scientists or for institutions? Friedmann T. The evolution of public review and oversight mechansims in human gene transfer research: joint roles of FDA and NIN. Curr Opin Biotechnol 12: 304–307

  11. Millstone E, Van Zwanenberg P . A crisis of trust: for science, scientists or for institutions? Gottweis H. Governing Molecules. The Discursive Politics of Genetic Engineering in Europe and in the United States. MIT Press: Cambrige, MA, 1998, pp 336–337

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H Gottweis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gottweis, H. Gene therapy and the public: a matter of trust. Gene Ther 9, 667–669 (2002). https://doi.org/10.1038/sj.gt.3301752

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3301752

Keywords

This article is cited by

Search

Quick links